Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
For a full breakdown of how AOD 9604 works, check out our companion article
Peptide therapy is popular for its relatively low side effects
GLP-1 drug penetration below 4% of eligible patients Top GLP-1 market: United States with 62.8% of global GLP-1 weight loss drug revenue Cardiovascular approval catalyst: Wegovy approved for MACE risk reduction following SELECT trial demonstrating 20% reduction in major adverse cardiovascular events Fastest-growing indication: Obstructive sleep apnea at 41.2% CAGR following Zepbound FDA approval November 2025 Market Overview: Why GLP-1 Weight Loss Drug Market Growth Is Accelerating The GLP-1 Weight Loss Drug Market is at an unprecedented commercial inflection point defined by three simultaneous demand accelerators
Recommended intake: Adults take 1ml (2 pumps) by mouth per day as required
**RI = Referentie inname is niet vastgesteld
While we are not aware of any contra-indications for pregnant or nursing women, Radiance requires written consent from a primary care provider or OB/GYN for patients who are pregnant and/or nursing
US$ 27.07
US$ 22.62
US$ 26.19
US$ 23.60
US$ 25.70
